Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $632.95 | 25 | 98.0% |
| Education | $13.17 | 1 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $173.43 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $116.98 | 1 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $60.04 | 4 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $55.88 | 3 | $0 (2019) |
| Merz North America, Inc. | $44.61 | 3 | $0 (2018) |
| Amgen Inc. | $38.07 | 2 | $0 (2021) |
| EMD Serono, Inc. | $32.75 | 2 | $0 (2019) |
| AbbVie, Inc. | $23.63 | 2 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $18.53 | 1 | $0 (2017) |
| Alexion Pharmaceuticals, Inc. | $16.98 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $219.87 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($116.98) |
| 2023 | $87.52 | 1 | UCB, Inc. ($87.52) |
| 2021 | $16.50 | 1 | Amgen Inc. ($16.50) |
| 2020 | $33.00 | 2 | Endo Pharmaceuticals Inc. ($33.00) |
| 2019 | $112.38 | 7 | Neurocrine Biosciences, Inc. ($40.70) |
| 2018 | $121.98 | 8 | Merz North America, Inc. ($33.82) |
| 2017 | $54.87 | 4 | Valeant Pharmaceuticals North America LLC ($18.53) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $116.98 | General |
| Category: IMMUNOLOGY | ||||||
| 03/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Rare Disease | ||||||
| 03/04/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $85.91 | General |
| Category: Neurology | ||||||
| 12/05/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $87.52 | General |
| 05/18/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Neuroscience | ||||||
| 02/20/2020 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: UROLOGY | ||||||
| 01/16/2020 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: UROLOGY | ||||||
| 11/05/2019 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), AVEED, EDEX | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: UROLOGY | ||||||
| 10/08/2019 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), AVEED, EDEX | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: UROLOGY | ||||||
| 10/03/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Education | In-kind items and services | $13.17 | General |
| Category: Neurology | ||||||
| 08/29/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Neuroscience | ||||||
| 08/15/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: NEUROLOGY | ||||||
| 06/20/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: NEUROLOGY | ||||||
| 05/09/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Neurology | ||||||
| 11/08/2018 | AbbVie, Inc. | Duopa (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Neuroscience | ||||||
| 08/30/2018 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: PD | ||||||
| 08/09/2018 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $16.58 | General |
| Category: MUSCULOSKELETAL | ||||||
| 08/06/2018 | AbbVie, Inc. | Duopa (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Neuroscience | ||||||
| 06/18/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Neuroscience | ||||||
| 03/21/2018 | Merz North America, Inc. | XEOMIN (Biological) | Food and Beverage | Cash or cash equivalent | $17.24 | General |
| Category: DERMATOLOGY | ||||||
| 02/07/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL DBS (Device) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: DBS | ||||||
| 01/24/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: NEUROLOGY | ||||||
| 12/14/2017 | Impax Laboratories, Inc. | RYTARY (Drug) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: NEUROLOGY | ||||||
| 10/05/2017 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 02/08/2017 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | Cash or cash equivalent | $10.79 | General |
| Category: Musculoskeletal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 595 | 900 | $300,284 | $64,540 |
| 2022 | 16 | 629 | 994 | $315,373 | $70,813 |
| 2021 | 16 | 620 | 991 | $307,376 | $69,980 |
| 2020 | 18 | 746 | 1,269 | $356,399 | $81,609 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 61 | 75 | $46,800 | $11,879 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 79 | 113 | $45,878 | $11,713 | 25.5% |
| G0453 | Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 2023 | 38 | 264 | $19,008 | $6,571 | 34.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 61 | 81 | $23,409 | $5,707 | 24.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 34 | $14,994 | $4,349 | 29.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 25 | 25 | $12,400 | $3,437 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 35 | 35 | $13,125 | $3,332 | 25.4% |
| 95913 | Nerve conduction, 13 or more studies | Facility | 2023 | 22 | 22 | $14,608 | $3,167 | 21.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 32 | $7,296 | $2,984 | 40.9% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2023 | 27 | 27 | $13,284 | $2,585 | 19.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 63 | 73 | $16,644 | $2,472 | 14.9% |
| 95861 | Needle measurement of electrical activity in arm or leg muscles, 2 extremities | Facility | 2023 | 37 | 37 | $21,053 | $2,329 | 11.1% |
| 95938 | Placement of skin electrodes and measurement of stimulated sites on arms and legs | Facility | 2023 | 37 | 37 | $30,340 | $1,297 | 4.3% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 14 | 14 | $5,712 | $1,142 | 20.0% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 20 | 20 | $6,240 | $1,094 | 17.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 11 | 11 | $9,493 | $482.57 | 5.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 74 | 96 | $59,224 | $15,758 | 26.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 68 | 87 | $33,162 | $9,689 | 29.2% |
| G0453 | Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 2022 | 40 | 322 | $23,344 | $8,121 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 63 | 78 | $20,634 | $5,750 | 27.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 26 | $11,490 | $3,786 | 33.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 36 | $11,376 | $3,462 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 28 | 28 | $10,230 | $2,874 | 28.1% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 11 | 16 | $8,500 | $2,551 | 30.0% |
| 95861 | Needle measurement of electrical activity in arm or leg muscles, 2 extremities | Facility | 2022 | 38 | 38 | $21,755 | $2,429 | 11.2% |
About Dr. Erin Phillips, MD
Dr. Erin Phillips, MD is a Internal Medicine healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114977949.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erin Phillips, MD has received a total of $646.12 in payments from pharmaceutical and medical device companies, with $219.87 received in 2024. These payments were reported across 26 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($632.95).
As a Medicare-enrolled provider, Phillips has provided services to 2,590 Medicare beneficiaries, totaling 4,154 services with total Medicare billing of $286,943. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Neurology
- Location Tyler, TX
- Active Since 05/11/2006
- Last Updated 06/17/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1114977949
Products in Payments
- HYQVIA (Biological) $116.98
- Zilbrysq (Drug) $85.91
- XIAFLEX (Biological) $60.04
- INGREZZA (Drug) $55.88
- Aimovig (Biological) $38.07
- XEOMIN (Biological) $33.82
- Mavenclad (Biological) $32.75
- Duopa (Drug) $23.63
- ULTRA (Device) $18.53
- ULTOMIRIS (Biological) $16.98
- NUEDEXTA (Drug) $14.72
- GENERAL DBS (Device) $14.12
- GOCOVRI (Drug) $13.66
- EMGALITY (Drug) $11.89
- RYTARY (Drug) $10.83
- Xeomin (Biological) $10.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tyler
Dr. Pamela Mcshane, M.d, M.D
Internal Medicine — Payments: $243,956
Thomas Buzbee, M.d, M.D
Internal Medicine — Payments: $123,613
Preetham Muskula, Md, MD
Internal Medicine — Payments: $89,345
Dr. Julie Philley, Md, MD
Internal Medicine — Payments: $68,306
Alexandre Petrakian, Md, MD
Internal Medicine — Payments: $37,685
Kai Xia, Md, MD
Internal Medicine — Payments: $24,476